Analyst Price Targets — KZR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 17, 2025 10:56 am | — | Wells Fargo | $5.00 | $4.17 | TheFly | Kezar Life Sciences price target lowered to $5 from $7 at Wells Fargo |
| October 17, 2025 8:50 am | Maury Raycroft | Jefferies | $7.00 | $4.17 | TheFly | Kezar Life Sciences downgraded to Hold from Buy at Jefferies |
| December 19, 2024 12:20 pm | Derek Archila | Wells Fargo | $9.00 | $6.26 | TheFly | Kezar Life Sciences price target lowered to $9 from $11 at Wells Fargo |
| August 12, 2022 7:02 am | — | H.C. Wainwright | $21.00 | $9.76 | Benzinga | HC Wainwright & Co. Maintains Buy on Kezar Life Sciences, Raises Price Target to $21 |
| May 4, 2022 8:34 am | — | Wells Fargo | $14.00 | $7.94 | Benzinga | Wells Fargo Maintains Overweight on Kezar Life Sciences, Lowers Price Target to $14 |
Latest News for KZR
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde and Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report.
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws
MILWAUKEE, April 07, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating Kezar (NASDAQ: KZR) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Aurinia.
Kezar Life Sciences (NASDAQ: KZR - Get Free Report) and Lifecore Biomedical (NASDAQ: LFCR - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, valuation, profitability, institutional ownership, dividends and analyst recommendations. Volatility and Risk Kezar Life Sciences
NEW YORK, March 30, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Kezar Life Sciences, Inc. (NASDAQ: KZR…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for KZR.
U.S. House Trading
No House trades found for KZR.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.